TrademarkDir
NASULIN
DEAD

Serial Number

77054463

Owner

Bentley Pharmaceuticals, Inc.

Attorney

Patrick J. Concannon

First Use Date

Feb 28, 2009

Filing Date

Nov 30, 2006

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

NASULIN Trademark

Serial Number: 77054463 • Registration: 3807419

NASULIN is a trademark filed by Bentley Pharmaceuticals, Inc. on November 30, 2006. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Bentley Pharmaceuticals, Inc. (8 trademarks)

4830 West Kennedy Boulevard, Suite 550
Tampa, FL 336092517

Entity Type: 03

CPEX PHARMACEUTICALS, INC. (5 trademarks)

2 HOLLAND WAY
EXETER, NH 03833

Entity Type: 03

Trademark Details

Filing Date

November 30, 2006

Registration Date

June 22, 2010

First Use Anywhere

February 28, 2009

First Use in Commerce

February 28, 2009

Published for Opposition

October 9, 2007

Cancellation Date

January 27, 2017

Goods & Services

pharmaceutical preparations for treating diabetes

Filing History

CANCELLED SEC. 8 (6-YR)
Jan 27, 2017 C8..
REGISTERED-PRINCIPAL REGISTER
Jun 22, 2010 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
May 20, 2010 SUNA
LAW OFFICE REGISTRATION REVIEW COMPLETED
May 19, 2010 REGV
ASSIGNED TO LIE
May 19, 2010 ALIE
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
May 11, 2010 CNPR
STATEMENT OF USE PROCESSING COMPLETE
May 11, 2010 SUPC
SOU EXTENSION 5 GRANTED
Mar 10, 2010 EX5G
USE AMENDMENT FILED
Mar 8, 2010 IUAF
SOU EXTENSION 5 FILED
Mar 8, 2010 EXT5
SOU TEAS EXTENSION RECEIVED
Mar 8, 2010 EEXT
TEAS STATEMENT OF USE RECEIVED
Mar 8, 2010 EISU
SOU EXTENSION 4 GRANTED
Feb 5, 2010 EX4G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 5, 2010 AITU
SOU EXTENSION 4 FILED
Dec 31, 2009 EXT4
SOU TEAS EXTENSION RECEIVED
Dec 31, 2009 EEXT
SOU EXTENSION 3 GRANTED
May 6, 2009 EX3G
SOU EXTENSION 3 FILED
May 6, 2009 EXT3
SOU TEAS EXTENSION RECEIVED
May 6, 2009 EEXT
SOU EXTENSION 2 GRANTED
Dec 29, 2008 EX2G
SOU EXTENSION 2 FILED
Dec 29, 2008 EXT2
SOU TEAS EXTENSION RECEIVED
Dec 29, 2008 EEXT
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Sep 17, 2008 ASGN
SOU EXTENSION 1 GRANTED
Jan 28, 2008 EX1G
SOU EXTENSION 1 FILED
Jan 28, 2008 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 28, 2008 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 28, 2008 TCCA
NOA MAILED - SOU REQUIRED FROM APPLICANT
Jan 1, 2008 NOAM
PUBLISHED FOR OPPOSITION
Oct 9, 2007 PUBO
NOTICE OF PUBLICATION
Sep 19, 2007 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 5, 2007 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 4, 2007 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 30, 2007 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 30, 2007 CRFA
ASSIGNED TO LIE
Aug 29, 2007 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 28, 2007 TROA
FINAL REFUSAL E-MAILED
May 16, 2007 GNFR
FINAL REFUSAL WRITTEN
May 16, 2007 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
May 1, 2007 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 1, 2007 CRFA
ASSIGNED TO LIE
May 1, 2007 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 2, 2007 TROA
NON-FINAL ACTION E-MAILED
Mar 30, 2007 GNRT
NON-FINAL ACTION WRITTEN
Mar 30, 2007 CNRT
ASSIGNED TO EXAMINER
Mar 27, 2007 DOCK
NEW APPLICATION ENTERED
Dec 5, 2006 NWAP

Related Trademarks

More from this Owner

CPEX PHARMACEUTICALS

CPEX PHARMACEUTICALS

CPEX PHARMACEUTICALS

CPEX PHARMACEUTICALS

CPEXIUM PHARMACEUTICALS

CPEXIUM PHARMACEUTICALS

CPEX PHARMACEUTICALS

CPEX PHARMACEUTICALS

CPEX PHARMACEUTICALS

CPEX PHARMACEUTICALS

CPEXIUM PHARMACEUTICALS

CPEXIUM PHARMACEUTICALS